»ù±¾ÐÅÏ¢
²úÆ·Æ·ÅÆ £º½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅƳÏÐÅÖÁÉÏ-Gold Annual MeetingÉúÎï
ÖÐÎÄÃû³Æ £ºÐ¡ÊóÁÜ°ÍÑùÁöϸ°û
ϸ°û¼ò³Æ £º P388D 1
ϸ°ûÐÎ̬ £º ÁÜ°Íĸϸ°ûÑù
Éú³¤ÌØÐÔ £º Ðü¸¡Ï¸°û
ÅàÑø»·¾³ £º ¿ÕÆø£¬95% £»CO2£¬5% 37¡æ
¶³´æÌõ¼þ £º 55% »ù´¡ÅàÑø»ù+40% FBS+5% D M SO Òºµª
ÍêÈ«ÅàÑø»ù £º RPM I-1640(P M 150110)£«10% H S(164215)£«1% P /S(P B 180120)
´«´ú²½Öè
¿Éͨ¹ý²¹³äÐÂÏÊÅàÑø»ù»òÕßÀëÐÄ»»ÒºÁ½ÖÖ·½Ê½Î¬³ÖÅàÑø£¬ÀëÐÄתËٲο¼1200 rpm £¨250g×óÓÒ£©£¬ÀëÐÄ3·ÖÖÓ
´«´ú±ÈÀý£¨Ãܶȣ© £º 2-5¡Á10^ 5cells/m L
»»ÒºÆµ´Î £º 2~ 3´Î/ÖÜ
ϸ°û±³¾°ÃèÊö
P388D 1ϸ°ûÀ´Ô´ÓÚ¼×»ùµ¨ÝìÓÕµ¼ÐγɵÄÁÜ°ÍÁö£»ÔÚLPSºÍ·ð²¨õ¥µÄÓÕµ¼Ï£¬P388D 1ϸ°û¿ÉÒÔ²úÉúIL-1£¬»¹¿ÉÒÔ²úÉúÈܾúø£»¿ÉÒÔÍÌÊɽÍĸ¶àÌǺÍÈ齺΢Çò£¬ÔÚ¿¹ÌåÒÀÀµµÄ¡¢Ï¸°û½éµ¼µÄϸ°û¶¾ÏµÍ³ÖÐÓлîÐÔ¡£P388D 1ϸ°û±íÃæÃâÒßÇòµ°°×(sIg)ÒõÐÔ£¬Ê󶻲¡¶¾ÒõÐÔ¡£
¹©ÌåÄêÁä £º ²»Ïê
×éÖ¯À´Ô´ £º ÁÜ°ÍÁö
ϸ°ûÀàÐÍ £º Ö×Áöϸ°û
Ö×ÁöÀàÐÍ £º ÁÜ°ÍÁöϸ°û
ÉúÎﰲȫµÈ¼¶ £º 1
ÖÂÁöÐÔ £º Yes,in nudemice(Tum orsdeveloped within 21 daysat100% frequ en cy
(5/5)in nudemiceinoculated subcutaneouslywith 1¡Á10^7 cells).
ϸ°û±£²ØÖÐÐÄ £º ATCC ; C C L-46
ÊÕµ½³£ÎÂϸ°ûºóÈçºÎ´¦Àí
ϸ°ûÅàÑøÏêϸ²Ù×÷²½ÖèÇë²ÎÕÕ½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅƳÏÐÅÖÁÉÏ-Gold Annual MeetingÉúÎïϸ°ûÅàÑø²Ù×÷Ö¸ÄÏ
1.ÊÕµ½³£ÎÂϸ°ûºó£¬¼°Ê±ÅÄÕռǼÓÐÎÞ©Һ/Æ¿ÉíÆÆËðÏÖÏó¡£
2.ÓÃ75%¾Æ¾«²ÁÊÃϸ°ûÅàÑøÆ¿±íÃ棬ÏÔ΢¾µÏ¹۲ìϸ°û״̬¡£ÏȲ»Òª´ò¿ªÅàÑøÆ¿¸Ç£¬½«Ï¸°ûÖÃÓÚϸ°ûÅàÑøÏäÄÚ¾²ÖÃÅàÑø2-4Сʱ£¬ÒÔ±ãÎȶ¨Ï¸°û״̬¡£
3.×ÐϸÔĶÁϸ°û˵Ã÷Ê飬Á˽âϸ°ûÏà¹ØÐÅÏ¢£¬ÈçÌù±ÚÌØÐÔ£¨Ìù±Ú/Ðü¸¡£©¡¢Ï¸°ûÐÎ̬¡¢ËùÓûù´¡ÅàÑø»ù¡¢ÑªÇå±ÈÀý¡¢ËùÐèϸ°ûÒò×Ó¡¢´«´ú±ÈÀý¡¢»»ÒºÆµÂʵȡ£
4.¾²ÖÃÍê³Éºó£¬È¡³öϸ°ûÅàÑøÆ¿£¬¾µ¼ì¡¢ÅÄÕÕ£¬¼Ç¼ϸ°û״̬£¨ËùÅÄÕÕƬ ½«×÷ΪºóÐø·þÎñÒÀ¾Ý£©£»½¨Òéϸ°û´«´úÅàÑøºó£¬¶¨ÆÚÅÄÕÕ¡¢¼Ç¼ϸ°ûÉú³¤×´Ì¬¡£
5.Èô¹Û²ìµ½Òì³£»òÕ߶Ôϸ°ûÓÐÒÉÎÊ£¬Ç뼰ʱ¸úÎÒÃÇÁªÏµ£»¶ÔÓÚϸ°ûÅàÑø²Ù×÷¼°ÅàÑø¡£¿É¸úÎÒÃǵļ¼ÊõÖ§³Ö½»Á÷¡£
ÊÛÇ°ÐëÖª
¸Ãϸ°ûΪÐü¸¡Ï¸°û£¬Çë×¢ÒâÀëÐÄÊÕ¼¯Ï¸°ûÐüÒº£»ÇëÎðÖ±½Óµ¹µôϸ°ûÅàÑøÒº¡£